abstract |
The present invention relates to a capsule-in-capsule composition comprising dabigatran etexilate in the form of the free base or in the form of pharmaceutically acceptable salts, polymorphs, solvates, hydrates or esters thereof characterized in that one of the capsules is filled with a liquid formulation. |